Non-Synthetic Color Spectrum Expands As FDA Approves Colorcon's Spirulina Extract Petition

Colorcon, Inc. recently announced the FDA’s approval of the Color Additive Petition (CAP 4C0300) submitted by Colorcon for the use of Spirulina Extract. This approval will allow the use of Spirulina Extract in coating formulations applied to dietary supplements, drug tablets and capsules marketed in the United States.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news